This is an updated NICE guideline on assessing and modifying cardiovascular disease risk, including lipid modification. It was last updated in May 2023 and has just been updated again in Dec 2023.
I will outline the changes, then do a more thorough summary below. I won’t include things that we all probably know to do anyway (e.g. around having a holistic discussion with the patient).
What has changed since the last update?
NICE last updated the guideline in May 2023. They have just updated the guidance (Dec 2023) to include separate targets for primary prevention and secondary prevention.